Ledger.Open graph →
SEC Form D · filed September 14, 2020

Avicenna Biosciences, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Thomas Kaiser · Durham, NCDirectorChristopher Meldrum · Durham, NCExec · DirectorPieter Burger · Durham, NCDirectorMichael A. Harstrick · Hingham, MADirectorAndrew Durgee · New York, NYDirectorJonathan A. Bronson · Hingham, MAExec · DirectorGreg Lyons · Dallas, TXDirectorTim Woodward · San Francisco, CAExec · DirectorKenneth Hood · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗